Jamie Dimon, chairman and CEO of JPMorgan Chase & Co., headlined a keynote address this morning at the 2019 BIO International Convention. He chatted with Jim Greenwood, president and CEO of BIO, about what drives him, what he learned from fighting throat cancer and how he would fix some of our…

Placing patients at the center of everything the biotech industry stands for is a personal mission for Christi Shaw. In 1996, her mother, Karen, died of breast cancer. It was a tragic time for her and her two sisters. But tragedy would strike again as Christi’s sister, Sherry, was later diagnosed…

A native of Wilmington, Delaware (Philadelphia’s neighbor to the south), and the child of two scientists, Stephen Tang was well aware of Philly’s University City Science Center, the nation’s first and largest urban research park. Little did he know that he would serve as its CEO for 10 years and in…

In a world of continual innovation in biopharmaceuticals, how do we ensure patients have access to the medicines that work to meet their individual needs? To discuss this important issue, we sat down with Merck Chief Patient Officer Dr. Julie Gerberding to discuss how we can better understand the…

We live in incredible times. AIDS is now largely treatable and preventable, cancer deaths are dropping, and gene therapy is advancing the war on disease. Innovation in the biotechnology industry is moving faster than ever before. Yet, much of our global population continues to lack access to…

Drug overdose deaths, including those involving opioids, reached 42,000 in 2016 (CDC), prompting a national response from the healthcare community to the sprawling crisis. The rise of opioid deaths appears to have occurred in three waves: first prescription opioids, followed by heroin, and most…

    On Tuesday morning at the 2019 BIO International Convention, COWEN CEO Jeffrey Solomon sat down for a fireside chat with Ovid Therapeutics CEO (and newly-elected BIO Chair) Dr. Jeremy Levin.   Levin introduced Solomon as a long-time passionate advocate for ensuring that small…

According to new census population projections, the U.S. will become ‘minority white’ by 2045. During that year, whites will comprise of 49.7 percent of the population, and more than 50 percent will be Hispanic, black, Asian and multiracial. Yet despite the passage of the National Institutes of…

It’s one thing to talk about the importance of diverse and inclusive workforces. It’s another thing to see it in action. During the opening day of the 2019 BIO International Convention, two panel sessions, The Science of Shattering the Lab’s Glass Ceiling and The Business Case for Diversity:…